Clinical Trial: A Prospective Cohort Study on the Impact of Biologics and Small-Molecule Targeted Drugs on the Progression of Subclinical Psoriatic Arthritis (China)

China, Sept. 17 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective Cohort Study on the Impact of Biologics and Small-Molecule Targeted Drugs on the Progression of Subclinical Psoriatic Arthritis'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132588

Registration Time: 2026/09/16

Type: Interventional study

Primary Sponsor: Shandong Provincial Hospital for Skin Diseases & Shandong Provincial Institute of Dermatology and Venerology, Shandong First Medical University & Shandong Academy of Medical Sciences

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=325062

Published by HT Digital Content Services with p...